Differential effects of low and high-dose estradiol on airway reactivity in ovariectomized rats.

The aim of this animal study was to test the hypothesis that low and high doses of 17beta-estradiol (E2) may differentially influence airway responsiveness. Ovariectomized female rats received either placebo or E2 (10 or 100 microg/kg per day) for 21 days. The concentration of inhaled acetylcholine (ACh) required to double pulmonary resistance (EC200 RL) was calculated as the in vivo index of airway responsiveness. Ex vivo airway responsiveness was evaluated by the cumulative concentration-response curve (CCRC) of isolated tracheal segments. Rats treated with low-dose E2 were less responsive to ACh than rats given either placebo or high-dose E2 (P=0.003). Ex vivo, low-dose E2 treatment decreased (P=0.01) and high-dose E2 increased the potency of ACh (P<0.001) compared to placebo. E2 treatment did not alter smooth muscle cross-sectional area or epithelium thickness. Accumulation of liquid within the tracheal mucosa was moderately enhanced by high-dose E2 treatment compared with animals given either placebo or low-dose E2 (P=0.03). We conclude that E2 treatment has differential, dose-dependent effects on airway responsiveness to acetylcholine.

Anticipating needs and designing new items rapidly - a case study for the design of postural aid equipment.

In this case study, designers proactively proposed new product ideas to a client by using an ergonomic approach. This approach differs from a more traditional approach where one works within a specific, clientdefined project. The methodology used included basic ergonomic techniques such as task analysis and information gathering sessions conducted with users. It was adapted so that these enriched user sessions could be conducted within a short time period. After meeting with five users in seven days, designers identified 20 problems that could be tackled and eight design ideas that could be implemented over the short, medium and long term. The ideas encompassed a wide range of potential projects, including physical product improvements, new product lines, Web-site and software improvements and longer term research. Problems identified and ideas generated involved many disciplines including occupational therapy, mechanical engineering, graphical design, software engineering, sales and manufacturing know-how. This wide range was possible because designers were not constrained to specific project scopes and timelines. The client was involved in the idea evaluation process. As a result of this study two new projects were initiated so far.

Human epidermis is a novel site of phospholipase B expression.

Phospholipase B (PLB) is an enzyme that displays both phospholipase A(2) and lysophospholipase activities. Analysis of human epidermis homogenates indicated the presence of a 97 kDa PLB protein, as well as a phospholipase A(2) activity, both being enriched in the soluble fraction. Immunolabelling and in situ hybridization experiments showed that this enzyme is expressed in the different layers of epidermis with an accumulation at the dermo-epidermis junction. RT-PCR data indicated that PLB is specifically expressed in natural and reconstructed epidermis. By 3'-RACE-PCR and screening of human genome databases, we obtained a 3600 bp cDNA coding for human PLB highly homologous to already described intestinal brush border PLBs. These data led us to conclude that the soluble PLB corresponds to a proteolytic cleavage of the membrane anchored protein. Altogether, our results provide the first characterization of human PLB which should play an important role in epidermal barrier function.